Clinical Trial Update: A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of Sisunatovir in healthy adult male participants. The study is rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED